Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: liraglutide, obesity, weight loss, GLP-1 receptor agonists, orlistat, body weight, tolerability, adverse events, energy deficit diet, physical activity, dose-response relationship, subcutaneous administration, non-diabetic obesity, open-label extension, weight regain, weight regain prevention, weight loss maintenance
Open Access status: closed
Funder: Novo Nordisk
OpenAlex ID: W2152835319
